Metformin lowers insulin levels in women with PCOS, which triggers a chain of improvements: less testosterone production, more regular periods, and a better metabolic profile overall. It’s one of the most commonly prescribed medications for PCOS because insulin resistance drives so many of the syndrome’s symptoms, from irregular cycles to acne to difficulty losing weight. While it’s not a cure, it addresses the hormonal root of the problem rather than masking individual symptoms.
How Metformin Targets the Root of PCOS
Most women with PCOS have some degree of insulin resistance, meaning their cells don’t respond well to insulin. The body compensates by producing more and more insulin, and those high insulin levels signal the ovaries to produce excess testosterone. That excess testosterone is what causes many of the visible symptoms of PCOS: acne, unwanted hair growth, thinning scalp hair, and disrupted ovulation.
Metformin makes your cells more responsive to insulin, so your body doesn’t need to pump out as much. It does this by activating a cellular energy sensor called AMPK, which improves how your cells take up and use glucose. At the same time, it dials down inflammatory signaling pathways that worsen insulin resistance. Women with PCOS tend to have elevated markers of chronic, low-grade inflammation, and metformin reduces the production of several key inflammatory molecules. This combined effect on both insulin sensitivity and inflammation is why metformin can improve so many different PCOS symptoms at once.
Effects on Testosterone and Hormones
Metformin treatment is associated with roughly a 20% reduction in testosterone levels. That drop matters because even a modest decrease can be enough to restart ovulation and begin improving androgen-driven symptoms like acne and excess hair growth. Lower insulin also means less stimulation of the adrenal glands, which are another source of androgens in PCOS.
The hormonal shift doesn’t happen overnight. Acne improvements typically become noticeable around three months. Excess hair growth and dark skin patches (acanthosis nigricans) take longer, generally six to twelve months, because hair growth cycles are slow and skin changes take time to reverse.
Restoring Ovulation and Periods
One of the most sought-after effects of metformin is getting periods back on track. In one study of 48 women with PCOS, 40% resumed spontaneous menstrual cycles and showed evidence of ovulation on metformin alone. For the women who didn’t ovulate on metformin by itself, adding a standard ovulation-inducing medication (clomiphene citrate) helped 67% of them ovulate.
Period regulation typically takes about six months of consistent use. The 2023 international evidence-based guidelines for PCOS note that metformin can be used on its own for anovulatory infertility, but they also acknowledge that other ovulation medications tend to be more effective. The strongest approach for fertility, according to these guidelines, is combining metformin with clomiphene citrate rather than using either drug alone. This combination improves both ovulation rates and clinical pregnancy rates.
Fertility and Pregnancy Rates
Among women who do ovulate on metformin (with or without additional medication), conception rates are encouraging. In the same study mentioned above, 42% of the 48 participants conceived, with a median time to conception of just three months. Among those who successfully ovulated, 69% became pregnant within six months. These numbers reflect a population with no other infertility factors beyond PCOS-related anovulation, so individual results vary depending on age, partner fertility, and other health conditions.
Weight and Metabolic Improvements
Metformin isn’t primarily a weight loss drug, but it does produce modest weight reduction in many women with PCOS. In a clinical study comparing dosages, women taking 1,500 mg daily lost an average of 3.3 kg (about 7 pounds), while those on 2,550 mg daily lost an average of 5.0 kg (about 11 pounds). The weight loss is gradual rather than dramatic, but it can be meaningful because even small reductions in body weight improve insulin sensitivity further.
The metabolic benefits go beyond the scale. After six months of treatment, one study found insulin levels dropped by 35%, total cholesterol fell by 11%, LDL (“bad”) cholesterol decreased by 12%, and triglycerides dropped by 33%. These changes bring lipid levels in women with insulin-resistant PCOS back in line with those seen in women who don’t have insulin resistance, which has real implications for long-term cardiovascular health.
Where Metformin Fits in Treatment Guidelines
The 2023 international PCOS guidelines give metformin a specific role depending on your symptoms and body weight. For women with a BMI of 25 or higher, metformin is recommended as a standalone option for improving insulin resistance, glucose levels, lipid profiles, and weight. For women with a BMI under 25, metformin may still be considered, though the evidence is more limited.
For menstrual irregularity and cosmetic concerns like hirsutism, oral contraceptives are generally preferred over metformin. But when metabolic health is the primary concern, metformin is favored over the pill. If oral contraceptives are contraindicated or not tolerated, metformin becomes an option for cycle regulation as well. In adolescents at risk for or already showing signs of PCOS, metformin can be considered for regulating cycles, though clinicians acknowledge the evidence base is still growing in this age group.
Myo-Inositol as an Alternative
Myo-inositol, a supplement that works on a similar insulin-signaling pathway, has gained popularity as a more “natural” option. A meta-analysis comparing the two found no statistically significant difference between metformin and myo-inositol in their effects on BMI, key reproductive hormones, testosterone levels, or insulin resistance scores, whether used for less than six months or for a full six months. Given that myo-inositol tends to cause fewer side effects, some women prefer it. However, metformin has a much deeper evidence base and remains the standard pharmaceutical option in clinical guidelines.
Dosage, Side Effects, and What to Expect
The typical starting dose is 500 mg once daily, gradually increased over several weeks to a maintenance dose of 1,500 to 1,700 mg per day. The maximum is 2,500 mg daily for adults and 2,000 mg for adolescents. This slow increase matters because the most common side effects, nausea, diarrhea, and bloating, are worst when you start or increase your dose and tend to ease as your body adjusts.
Three strategies reduce digestive issues significantly: always take metformin with food, start at a low dose and increase gradually, and ask about the extended-release formulation, which causes fewer GI symptoms than the standard version. Most people tolerate metformin well once they’ve adjusted, and the side effects that do occur are generally mild.
In terms of timeline, here’s a realistic picture of when to expect changes:
- Insulin and blood sugar levels: improvements begin within weeks
- Acne: noticeable improvement around 3 months
- Menstrual regularity: roughly 6 months
- Excess hair growth and dark skin patches: 6 to 12 months
- Lipid profile changes: measurable by 3 to 6 months
The slow timeline for visible symptoms is one reason many women feel discouraged and stop treatment too early. Sticking with it for at least six months gives you the best chance of seeing the full range of benefits.